saqib

Home|Saqib Siddiqui

About Saqib Siddiqui

Muhammad Saqib Siddiqui has been working in the Dimension Research as a Project Manager Patient Support Program.

PhV Training at Cancer Foundation Hospital, Karachi

Dimension Research has conducted training program on “Pakistan Pharmacovigilance Guidelines & ADR Reporting System” in Cancer Foundation Hospital on Thursday, 29th July 2021. Dr. Lubna Senior Oncologist in Cancer Foundation Hospital Karachi requested DR to conduct a training session in his department and showed interest to establish ADR reporting system as per federal guidelines.

By |2021-08-06T06:47:18+00:00August 6th, 2021|Latest News|0 Comments

Pharmacovigilance Services Sponsored By Dimension Research At KMDC

Dimension Research CRO&SMO has facilitated KMDC to establish Vaccination Center, where number of students, staff and public are being vaccinated under the supervision of doctors. Dimension Research has not only assisted in printing of forms and vaccination cards but also provided resources and trained their staff on “Pharmacovigilance and ADR Reporting System” as per

By |2021-07-05T05:59:18+00:00July 5th, 2021|Latest News|0 Comments

Dimension Research Efforts Acknowledged at National Level

University of Health Science, Lahore has organized Pakistan First International Conference on Covid-19 Vaccine and Beyond” at Lahore on 10th April 2021. Prof. Dr. Jawed Akram, Vice Chancellor of University of Health Sciences appreciated the study and site management efforts of Dimension Research in the largest Phase III Covid 19 Vaccine study conducted in

By |2021-04-19T07:17:57+00:00April 19th, 2021|Latest News|0 Comments

Dimension Research a partner in Pak-China Medical History

 National Medical Products Administration (NMPA) formerly CFDA has conducted inspection of two sites for CanSino, Bio COVID Vaccine Phase III study in Pakistan in Feb 2021.  After a detailed evaluation of study data, interview with the site, CRO and sponsor personnel; they have given satisfactory remarks on the development, conduct and data quality of

By |2021-03-04T08:34:49+00:00March 4th, 2021|Latest News|0 Comments

COVID-19 Vaccine Approval – A Historical moment for Dimension Research

Drug Regulatory Authority Pakistan (DRAP) has given their first ever approval of a new molecule on indigenous data. Cansino Bio COVID 19 Vaccine has been approved in Feb 2021 for EUA by DRAP after evaluation of interim analysis of >17000 Pakistani subject. Dimension Research has the honor to provide site regulatory, management and monitoring

By |2021-03-04T08:18:29+00:00March 4th, 2021|Latest News|0 Comments

DR Team-Annual Lunch

Dimension Research has organized annual lunch for its Karachi teams at Marriott Hotel Karachi on Saturday, 2nd January 2021. Clinical Research, Patient supports programs teams (UNMOL, Hamqadam, Maseeha and Lantus Aasaan) teams and head office staff participated and enjoyed the luscious lunch. The expanding Dimension family get to know each other and discuss their

By |2021-01-11T06:32:50+00:00January 11th, 2021|Latest News|0 Comments

World Diabetes Day With Dr. Ahsan Siddiqui In Sehwan City

Dimension Research team took part in a walk organized by Syed Abdullah Shah Medical Hospital, Sehwan City on Saturday, 28th November 2020. The World Diabetes Day was observed where a seminar was held in which a large number of patients, doctors and paramedical staff participated. Addressing the seminar, Dr. Ahsan Siddiqui advised patients to

By |2020-12-17T10:36:00+00:00December 17th, 2020|Latest News|0 Comments

ICH-GCP Training at National Institute of Health-Islamabad

Dimension Research has conducted a two days comprehensive training program on “International Conference on Harmonization-Good Clinical Practice” (ICH-GCP) at NIH Islamabad on 2nd and 3rd Sep 2020. Participants of this training were personnel involved in the upcoming land mark COVID 19 Vaccine Phase III study. Maj Gen Aamir Ikram (Executive Director NIH) and the

By |2020-09-14T11:22:58+00:00September 14th, 2020|Latest News|0 Comments

Dimension Research CRO&SMO Selected as Monitor in First Phase III COVID-19 Vaccine Study

ISLAMABAD/KARACHI: The Drug Regulatory Authority of Pakistan (DRAP) on Monday gave its approval to the National Institute of Health (NIH) to conduct the Phase III clinical trial of a coronavirus vaccine, making it the first one ever in the country. According to a statement from the NIH, the medical facility has obtained "the formal

By |2020-08-18T10:32:50+00:00August 18th, 2020|Latest News|0 Comments

PhV Training at Prof. Dr. Majid Ali Abidi Clinic – The Brain Clinic, Taj Medical Complex, Karachi

Dimension Research has conducted training program on “Pakistan Pharmacovigilance Guidelines & ADR Reporting System” at Prof. Dr. Majid Ali Abidi clinic - The Brain Clinic, Taj Medical Complex, Karachi on Thursday, 6th August 2020. Prof. Dr. Majid Ali Abidi showed his interest to establish ADR reporting system as per national guidelines and to conduct a

By |2020-08-17T12:00:00+00:00August 17th, 2020|Latest News|0 Comments